Literature DB >> 3422334

Possible association of human growth hormone treatment with an occurrence of acute myeloblastic leukemia with an inversion of chromosome 3 in a child of pituitary dwarfism.

M Endo1, Y Kaneko, T Shikano, H Minami, J Chino.   

Abstract

An 11-yr-old girl, who had been treated with human growth hormone (h-GH) for 31 months, developed acute myeloblastic leukemia with an inv(3)(q21q26). Since GH has been suggested to influence the genesis of leukemia, and the inversion 3 has been reported only in adult leukemia patients, the GH treatment may have caused the development of leukemia or accelerated the proliferation of the leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422334     DOI: 10.1002/mpo.2950160111

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  6 in total

Review 1.  Chromosome abnormalities in acute leukemia: its clinical implications and age of onset.

Authors:  R Abe; Y Shiga; T Uchida; S Kariyone
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 2.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

3.  Malignant thymoma in a patient with growth hormone deficiency during growth hormone therapy.

Authors:  T Hasegawa; Y Hasegawa; S Koto; T Aso; Y Tsuchiya; A Hayashi; H Ishida; Y Morikawa
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

Review 4.  Acute myeloid leukemia and colon carcinoma during the course of acromegaly.

Authors:  Kazutaka Ozeki; Yoshihisa Morishita; Sigeki Saito; Koji Umemura; Yohei Yamaguchi; Shotaro Tatekawa; Koichi Watamoto; Akio Kohno; Tsuyoshi Nogimori
Journal:  Int J Hematol       Date:  2013-09-24       Impact factor: 2.490

Review 5.  Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance.

Authors:  Stefano Cianfarani
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-24       Impact factor: 5.555

6.  Risk factors for leukemia occurrence among growth hormone users.

Authors:  S Watanabe; N Yamaguchi; Y Tsunematsu; A Komiyama
Journal:  Jpn J Cancer Res       Date:  1989-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.